Recombinant Vaccine Market Size, Share

Global Recombinant Vaccine Market Report By Product (Subunit Recombinant Vaccine, Attenuated Recombinant Vaccine And Vector Recombinant Vaccine), End-User (Recombinant Human Vaccine And Animal Recombinant Vaccine) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026

ID:VMR11210560

February 2020

Report Formats:

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Description
Table Of Content

As per this study the Global Recombinant Vaccine Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of X.X%. By volume, the market was estimated XX.X KT in 2019 and is expected to reach XX.X KT by 2026 with a CAGR of X.X%.

Recombinant vaccine refers to the biological suspension developed using recombinant DNA technology. The recombinant vaccine is produced by introducing genetic material of dead or attenuated antigen into the host body through a vector that results in stimulation of immune response. It is useful to offer resistance to malaria, typhoid, allergies, cancer, and various infectious diseases such as Ebola, Flu, HPV, measles, smallpox, etc.

Market Dynamics

Growing health threat on account of widespread of infectious diseases and increasing prevalence of cancer is driving the market growth. Rise in immunization programs by the government to promote resistant to diseases is further fueling the market demand. Ongoing advancement in the field of immunology, molecular biology, biochemistry, genomics, and proteomics is again boosting the market growth.

This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of recombinant vaccine.

Market Segmentation

The broad recombinant vaccine market has been sub-grouped into product and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.

By Product

Subunit Recombinant Vaccine
Attenuated Recombinant Vaccine
Vector Recombinant Vaccine

By End-User

Recombinant Human Vaccine
Animal Recombinant Vaccine

Regional Analysis

Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for recombinant vaccine in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.

Europe Recombinant Vaccine Market By Revenue (USD MN)

The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the recombinant vaccine market include Bayer AG, Bharat Biotech, GlaxoSmithKline Plc., Green Cross Corporation, Merck & Co., Inc., Novartis AG, Pfizer Inc., Protein Science Corporation and Sanofi S A. among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.

METHODOLOGY:

A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Recombinant Vaccine Market
       2.2. Global Recombinant Vaccine Market Snapshot

3 . RECOMBINANT VACCINE – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Recombinant Vaccine Market
       3.3. Market Restraints of Recombinant Vaccine Market
       3.4. Opportunities of Recombinant Vaccine Market
       3.5. Trends of Recombinant Vaccine Market
       3.6. Porter’s Five Force Analysis of Recombinant Vaccine Market
       3.7. Recombinant Vaccine Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Product
           3.7.2 Market Attractive Analysis by End-User
           3.7.3 Market Attractive Analysis by Region

4 . VALUE CHAIN ANALYSIS
       4.1. Recombinant Vaccine Value Chain Analysis
       4.2. Recombinant Vaccine Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Recombinant Vaccine Raw Material Manufactures List
           4.2.3. Price Trend of Recombinant Vaccine Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . GLOBAL RECOMBINANT VACCINE MARKET ANALYSIS BY PRODUCT
       5.1 Overview by Product
       5.2 Global Recombinant Vaccine Market Analysis by Product
       5.3 Market Analysis of Subunit Recombinant Vaccine by Regions
       5.4 Market Analysis of Attenuated Recombinant Vaccine by Regions
       5.5 Market Analysis of Vector Recombinant Vaccine by Regions

6 . GLOBAL RECOMBINANT VACCINE MARKET ANALYSIS BY END-USER
       6.1 Overview by End-User
       6.2 Global Recombinant Vaccine Market Analysis by End-User
       6.3 Market Analysis of Recombinant Human Vaccine by Regions
       6.4 Market Analysis of Animal Recombinant Vaccine by Regions

7 . GLOBAL RECOMBINANT VACCINE MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Recombinant Vaccine Market Estimate by Market Segment
           7.3.3. North America Recombinant Vaccine Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Recombinant Vaccine Market Estimate by Market Segment
           7.4.3. Europe Recombinant Vaccine Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Recombinant Vaccine Market Estimate by Market Segment
         7.5.3. Asia Pacific Recombinant Vaccine Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Recombinant Vaccine Market Estimate by Market Segment
           7.6.3. Latin America Recombinant Vaccine Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Recombinant Vaccine Market Estimate by Market Segment
           7.7.3. Middle East & Africa Recombinant Vaccine Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa

8 . COMPETITIVE LANDSCAPE OF THE RECOMBINANT VACCINE COMPANIES
       8.1. Recombinant Vaccine Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments

9 . COMPANY PROFILES OF RECOMBINANT VACCINE INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Bayer AG
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Bharat Biotech
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. GlaxoSmithKline Plc.
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Green Cross Corporation
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. Merck & Co., Inc
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. Novartis AG
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Pfizer Inc.
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
       9.10. Protein Science Corporation
           9.10.1. Company Overview
           9.10.2. Financials
           9.10.3. Products
           9.10.4. Recent Developments
       9.11. Sanofi S A.
           9.11.1. Company Overview
           9.11.2. Financials
           9.11.3. Products
           9.11.4. Recent Developments

10. IMPACT ANALYSIS OF COVID-19 OUTBREAK
10.1. Impact Analysis of Covid-19 Outbreak on the Market
10.1.1. Direct Impact on Production
10.1.2. Supply Chain and Market Disruption
10.1.3. Financial Impact on Firms and Financial Markets
10.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
10.3. Pre V/S Post COVID-19 Market
10.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Market Size in 2020, by Scenario
10.5. COVID-19: Micro and Macro Factor Analysis on the Market

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

Research Scope of Recombinant Vaccine Report
Market Research Process
Market Research Methodology
Global Recombinant Vaccine Market Size, by Region (2019)
Porters Five Forces Analysis
Market Attractiveness Analysis by Product
Market Attractiveness Analysis by End-User
Market Attractiveness Analysis by Region
Value Chain Analysis
Global Recombinant Vaccine Market Analysis by Product
Global Recombinant Vaccine Market Analysis in Subunit Recombinant Vaccine by Region
Global Recombinant Vaccine Market Analysis in Attenuated Recombinant Vaccine by Region
Global Recombinant Vaccine Market Analysis in Vector Recombinant Vaccine by Region
Global Recombinant Vaccine Market Analysis by End-User
Global Recombinant Vaccine Market Analysis in Recombinant Human Vaccine by Region
Global Recombinant Vaccine Market Analysis in Animal Recombinant Vaccine by Region
Global Recombinant Vaccine Market by Volume And Revenue
North America Recombinant Vaccine Market by Volume And Revenue
Europe Recombinant Vaccine Market by Volume And Revenue
Asia Pacific Recombinant Vaccine Market by Volume And Revenue
Latin America Recombinant Vaccine Market by Volume And Revenue
Middle East & Africa Recombinant Vaccine Market by Volume And Revenue
Recent Development in Recombinant Vaccine Industry
Company Market Share Analysis, 2019

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "

ID:VMR11210560

February 2020

Report Formats:

Choose your Buying Option

Choose your Buying Option

Objectives of Study

Buy Chapters or Sections

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

Vincenzo Baydar – Head Planning, Leading Food Chain, US

Mia Tang, Director - Business Strategy, Steel Industry, Germany

Jo Chin, Owner of a Manufacturing Plant in Taiwan

Key questions answered by the report

Need specific market information?

ID:VMR11210560

February 2020

Report Formats:

Choose your Buying Option

Choose your Buying Option

Objectives of Study

Buy Chapters or Sections

Why Choose Us

Client First Policy

Excellent Quality

Robust After Sales Support

24/7 Email Support

Clients

Testimonials

Vincenzo Baydar – Head Planning, Leading Food Chain, US

Mia Tang, Director - Business Strategy, Steel Industry, Germany

Jo Chin, Owner of a Manufacturing Plant in Taiwan

Key questions answered by the report

Need specific market information?

Important: Covid19 pandemic market impact